| Identification | Back Directory | [Name]
4-fluoro-2-methoxy-3-nitrobenzenamine | [CAS]
2090542-75-7 | [Synonyms]
10296-11071
Osimertinib Impurity 35
4-fluoro-2-methoxy-3-nitroaniline
4-fluoro-2-methoxy-3-nitrobenzenamine
Benzenamine, 4-fluoro-2-methoxy-3-nitro- | [Molecular Formula]
C7H7FN2O3 | [MDL Number]
MFCD32670672 | [MOL File]
2090542-75-7.mol | [Molecular Weight]
186.14 |
| Chemical Properties | Back Directory | [Boiling point ]
343.3±37.0 °C(Predicted) | [density ]
1.412±0.06 g/cm3(Predicted) | [pka]
2.30±0.10(Predicted) | [InChI]
InChI=1S/C7H7FN2O3/c1-13-7-5(9)3-2-4(8)6(7)10(11)12/h2-3H,9H2,1H3 | [InChIKey]
YSVDABATHQBBKE-UHFFFAOYSA-N | [SMILES]
C1(N)=CC=C(F)C([N+]([O-])=O)=C1OC |
| Hazard Information | Back Directory | [Uses]
4-Fluoro-2-methoxy-3-nitro-benzenamine is an impurity from the synthesis of Osimertinib (A808075), a selective EGFR inhibitor (epidermal growth factor receptor) used in the treatments of nonsmall-cell lung cancer. |
|
|